Coty, Inc.

As of May 6, 2025, Coty, Inc. is considered overvalued and risky, with a P/E ratio of 24, underperforming the S&P 500 by -53.89% over the past year, while peers like Reynolds Consumer Products and Inter Parfums show more favorable valuation metrics.

As of May 6, 2025, Coty, Inc. is considered overvalued with a risky valuation grade, reflected by a P/E ratio of 24 and significant underperformance, including a 30.75% year-to-date decline compared to the S&P 500's 2.44% gain.

As of May 27, 2025, the market trend is mildly bearish, indicated by mixed signals from MACD, RSI, moving averages, and Bollinger Bands, suggesting caution with a slight bearish bias.

As of March 2022, the management team of Coty, Inc. includes Dr. Gerd Harf (Executive Chairman), Ms. Sue Nabi (CEO), and several directors, including Mr. Johannes Huth (Independent Vice Chairman) and Mr. Robert Singer (Lead Independent Director), among others. They oversee the company's strategic direction and operations.

Coty, Inc. is a mid-cap beauty company that produces and sells fragrance, color cosmetics, and skin care products. As of March 2025, it reported net sales of $1.299 billion and a net profit of -$402 million.

As of Jun 18, Coty, Inc. has a market capitalization of 4,636.63 million and reported net sales of 6,003.90 million with a net profit of -376.50 million for the latest four quarters.